155 related articles for article (PubMed ID: 10575293)
1. Evidence of altered homocysteine metabolism in chronic renal failure.
Henning BF; Riezler R; Tepel M; Langer K; Raidt H; Graefe U; Zidek W
Nephron; 1999; 83(4):314-22. PubMed ID: 10575293
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease.
Herrmann W; Schorr H; Geisel J; Riegel W
Clin Chem Lab Med; 2001 Aug; 39(8):739-46. PubMed ID: 11592444
[TBL] [Abstract][Full Text] [Related]
3. [Homocysteine and its metabolites in chronic renal insufficiency and the effect of a vitamin replacement].
Henning BF; Tepel M; Graefe U; Zidek W
Med Klin (Munich); 2000 Sep; 95(9):477-81. PubMed ID: 11028163
[TBL] [Abstract][Full Text] [Related]
4. Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry--comparison with the Abbott IMx homocysteine assay and the HPLC method.
Sigit JI; Hages M; Brensing KA; Frotscher U; Pietrzik K; von Bergmann K; Lütjohann D
Clin Chem Lab Med; 2001 Aug; 39(8):681-90. PubMed ID: 11592433
[TBL] [Abstract][Full Text] [Related]
5. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
Obeid R; Kuhlmann MK; Köhler H; Herrmann W
Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of amino acids in cats with severe cobalamin deficiency.
Ruaux CG; Steiner JM; Williams DA
Am J Vet Res; 2001 Dec; 62(12):1852-8. PubMed ID: 11763170
[TBL] [Abstract][Full Text] [Related]
7. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?
Look MP; Riezler R; Reichel C; Brensing KA; Rockstroh JK; Stabler SP; Spengler U; Berthold HK; Sauerbruch T
Scand J Gastroenterol; 2000 Aug; 35(8):866-72. PubMed ID: 10994627
[TBL] [Abstract][Full Text] [Related]
8. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Herrmann W; Schorr H; Obeid R; Makowski J; Fowler B; Kuhlmann MK
Clin Chem; 2005 May; 51(5):891-7. PubMed ID: 15774574
[TBL] [Abstract][Full Text] [Related]
9. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
10. [Some aspects of homocysteine metabolism in hemodialysis patients].
Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
12. Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency.
Herrmann W; Hübner U; Koch I; Obeid R; Retzke U; Geisel J
Clin Chem Lab Med; 2004; 42(10):1109-16. PubMed ID: 15552268
[TBL] [Abstract][Full Text] [Related]
13. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of vitamin B(12), folate, and vitamin B(6) supplements in elderly people with normal serum vitamin B(12) concentrations.
Henning BF; Tepel M; Riezler R; Naurath HJ
Gerontology; 2001; 47(1):30-5. PubMed ID: 11244289
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.
Herrmann W; Obeid R
Clin Chem Lab Med; 2005; 43(10):1039-47. PubMed ID: 16197295
[TBL] [Abstract][Full Text] [Related]
16. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
17. Does a single vitamin B-supplementation induce functional vitamin B-deficiency?
Naurath HJ; Riezler R; Pütter S; Ubbink JB
Clin Chem Lab Med; 2001 Aug; 39(8):768-71. PubMed ID: 11592449
[TBL] [Abstract][Full Text] [Related]
18. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Franke S; Müller A; Sommer M; Busch M; Kientsch-Engel R; Stein G
Clin Nephrol; 2003 Feb; 59(2):88-97. PubMed ID: 12608551
[TBL] [Abstract][Full Text] [Related]
20. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Kaplan LN; Mamer OA; Hoffer LJ
Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
